Feng Chi Biotech Corp. (TPEX:6744)

Feng Chi Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	179.94	171.1	180.58	193.46	182.57	178.91
Revenue Growth (YoY)	3.76%	-5.25%	-6.66%	5.96%	2.05%	2.63%
Cost of Revenue	100.4	93.95	99.86	110.02	96.46	92.98
Gross Profit	79.54	77.15	80.72	83.44	86.11	85.92
Selling, General & Admin	49.56	46.43	43.46	44.29	45.48	45.43
Research & Development	14.75	14.6	13.1	12.09	14.19	11.91
Operating Expenses	64.31	61.03	56.56	56.38	59.67	57.34
Operating Income	15.23	16.12	24.16	27.07	26.44	28.58
Interest Expense	-0.22	-0.25	-0.33	-0.06	-0.1	-0.17
Interest & Investment Income	3.21	3.24	3.09	1.88	1.38	1.85
Currency Exchange Gain (Loss)	-0.59	0.68	0.34	1.5	0.01	-0.56
Other Non Operating Income (Expenses)	0.54	0.54	0.03	0.03	0.13	0.13
EBT Excluding Unusual Items	18.18	20.33	27.3	30.42	27.86	29.83
Gain (Loss) on Sale of Assets	-	-	-	-	0.2	-
Pretax Income	18.18	20.33	27.3	30.42	28.06	29.83
Income Tax Expense	2.54	3.74	4.51	5.81	4.92	4.43
Net Income	15.64	16.59	22.79	24.61	23.14	25.39
Net Income to Common	15.64	16.59	22.79	24.61	23.14	25.39
Net Income Growth	-18.91%	-27.19%	-7.40%	6.39%	-8.89%	46.29%
Shares Outstanding (Basic)	15	15	15	15	15	15
Shares Outstanding (Diluted)	15	15	15	15	15	15
Shares Change (YoY)	-0.15%	0.02%	-0.07%	0.08%	0.01%	3.16%
EPS (Basic)	1.02	1.08	1.48	1.60	1.50	1.65
EPS (Diluted)	1.01	1.07	1.47	1.60	1.50	1.64
EPS Growth	-18.59%	-27.21%	-8.03%	6.55%	-8.54%	41.38%
Free Cash Flow	-7.44	10.46	14.02	28.4	31.83	36.22
Free Cash Flow Per Share	-0.48	0.68	0.91	1.84	2.06	2.34
Dividend Per Share	0.950	0.950	1.050	1.350	1.250	1.150
Dividend Growth	-9.52%	-9.52%	-22.22%	8.00%	8.70%	27.78%
Gross Margin	44.20%	45.09%	44.70%	43.13%	47.16%	48.03%
Operating Margin	8.46%	9.42%	13.38%	13.99%	14.48%	15.98%
Profit Margin	8.69%	9.70%	12.62%	12.72%	12.67%	14.19%
Free Cash Flow Margin	-4.14%	6.11%	7.76%	14.68%	17.43%	20.24%
EBITDA	23.57	22.62	28.66	30.67	32.53	35.77
EBITDA Margin	13.10%	13.22%	15.87%	15.85%	17.82%	19.99%
D&A For EBITDA	8.34	6.5	4.5	3.6	6.09	7.18
EBIT	15.23	16.12	24.16	27.07	26.44	28.58
EBIT Margin	8.46%	9.42%	13.38%	13.99%	14.48%	15.98%
Effective Tax Rate	13.98%	18.39%	16.51%	19.08%	17.55%	14.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.